BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 34988021)

  • 1. Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting.
    Hourani T; Holden JA; Li W; Lenzo JC; Hadjigol S; O'Brien-Simpson NM
    Front Oncol; 2021; 11():788365. PubMed ID: 34988021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting tumor-associated macrophages for cancer immunotherapy.
    Cao X; Lai SWT; Chen S; Wang S; Feng M
    Int Rev Cell Mol Biol; 2022; 368():61-108. PubMed ID: 35636930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of tumor-associated macrophage in breast cancer biology.
    Choi J; Gyamfi J; Jang H; Koo JS
    Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Macrophages in Cancer Development and Therapy.
    Cendrowicz E; Sas Z; Bremer E; Rygiel TP
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting macrophages: a novel treatment strategy in solid tumors.
    Liu M; Liu L; Song Y; Li W; Xu L
    J Transl Med; 2022 Dec; 20(1):586. PubMed ID: 36510315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Associated Macrophage Targeting of Nanomedicines in Cancer Therapy.
    Kang X; Huang Y; Wang H; Jadhav S; Yue Z; Tiwari AK; Babu RJ
    Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38258072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Osteopontin in Tumor Progression Through Tumor-Associated Macrophages.
    Tan Y; Zhao L; Yang YG; Liu W
    Front Oncol; 2022; 12():953283. PubMed ID: 35898884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated macrophages: an accomplice in solid tumor progression.
    Chen Y; Song Y; Du W; Gong L; Chang H; Zou Z
    J Biomed Sci; 2019 Oct; 26(1):78. PubMed ID: 31629410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy.
    Schweer D; McAtee A; Neupane K; Richards C; Ueland F; Kolesar J
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor-Glioma Therapy?
    Tong N; He Z; Ma Y; Wang Z; Huang Z; Cao H; Xu L; Zou Y; Wang W; Yi C; Yin Z; Wang Q
    Front Cell Dev Biol; 2021; 9():706286. PubMed ID: 34368156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies.
    Kumari N; Choi SH
    J Exp Clin Cancer Res; 2022 Feb; 41(1):68. PubMed ID: 35183252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor therapy for breast cancer: Focus on tumor-associated macrophages and nanosized drug delivery systems.
    Zhan C; Jin Y; Xu X; Shao J; Jin C
    Cancer Med; 2023 May; 12(10):11049-11072. PubMed ID: 36794651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated macrophages in liver cancer: From mechanisms to therapy.
    Cheng K; Cai N; Zhu J; Yang X; Liang H; Zhang W
    Cancer Commun (Lond); 2022 Nov; 42(11):1112-1140. PubMed ID: 36069342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking LTB
    Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
    Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting tumor-associated macrophages: A potential treatment for solid tumors.
    Chen Y; Jin H; Song Y; Huang T; Cao J; Tang Q; Zou Z
    J Cell Physiol; 2021 May; 236(5):3445-3465. PubMed ID: 33200401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages.
    Ngambenjawong C; Cieslewicz M; Schellinger JG; Pun SH
    J Control Release; 2016 Feb; 224():103-111. PubMed ID: 26772876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting tumor-associated macrophages for cancer treatment.
    Li M; He L; Zhu J; Zhang P; Liang S
    Cell Biosci; 2022 Jun; 12(1):85. PubMed ID: 35672862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy.
    Huang L; Xu R; Li W; Lv L; Lin C; Yang X; Yao Y; Saw PE; Xu X
    Acta Biomater; 2023 May; 162():98-109. PubMed ID: 36931417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting tumor-associated macrophages in the tumor microenvironment.
    Zhou K; Cheng T; Zhan J; Peng X; Zhang Y; Wen J; Chen X; Ying M
    Oncol Lett; 2020 Nov; 20(5):234. PubMed ID: 32968456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs); where do they stand in tumorigenesis and how they can change the face of cancer therapy?
    Tajaldini M; Saeedi M; Amiriani T; Amiriani AH; Sedighi S; Mohammad Zadeh F; Dehghan M; Jahanshahi M; Zanjan Ghandian M; Khalili P; Poorkhani AH; Alizadeh AM; Khori V
    Eur J Pharmacol; 2022 Aug; 928():175087. PubMed ID: 35679891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.